ViiV’s fostemsavir yields positive week 96 results in phase 3 HIV-1 trial

Image: ViiV Healthcare reports positive week 96 data for fostemsavir in BRIGHTE study. Photo: courtesy of PublicDomainPictures/Pixabay.